Anti-FOXP3 antibody [236A/E7]
- BOND RX™ Validated
- Recombinant
- Lab Essentials
- Advanced Validation
- What is this?
4
(38 Reviews)
|
(746 Publications)
Anti-FOXP3 antibody [236A/E7] (ab20034) is a mouse monoclonal antibody detecting FOXP3 in Western Blot, IHC-P, mIHC. Suitable for Human.
- Multiplex IHC validated on the Leica BOND® MAX using Opal reagents
- Over 590 publications
- Trusted since 2005
View Alternative Names
IPEX, JM2, FOXP3, Forkhead box protein P3, Scurfin
- mIHC
Collaborator
Multiplex immunohistochemistry - Anti-FOXP3 antibody [236A/E7] (AB20034)
Fluorescence multiplex immunohistochemical analysis of Human breast cancer tissue (formalin-fixed paraffin-embedded section).
Merged staining of Anti-PD-L1 (ab251611; cyan; Opal™ 520), Anti-Granzyme B (ab219803; yellow; Opal™ 540), Anti-PD1 (ab251613; magenta; Opal™ 570), Anti-pan Cytokeratin (ab264485; red; Opal™ 620), Anti-EpCAM (ab225894; red; Opal™ 620), Anti-CD8 alpha (ab251596; green; Opal™ 650) and Anti-FOXP3 (ab96048; orange; Opal™ 690). EpCAM and pan-cytokeratin share the same dye and color. Dyes are pseudo-colored for better contrast of the markers.
The immunostaining was performed on a Leica Biosystems BOND® MAX instrument with an Opal™ 6-Plex Detection Kit (NEL821001KT, Akoya Biosciences®).
The section was incubated in six rounds of staining; sequentially for ab251611 (1/750 dilution), ab219803 (1/250 dilution), ab251613 (1/750 dilution), ab264485 (0.5 μg/ml), ab225894 (1/1250 dilution), ab251596 (1/1500 dilution) and ab96048 (10 μg/ml); each using a separate fluorescent tyramide signal amplification system. EDTA based antigen retrieval (Leica Biosystems BOND® Epitope Retrieval Solution 2, pH 9.0, 20 minutes) was used in between rounds of tyramide signal amplification to remove the antibody from the previous round, to avoid any cross-reactivity. DAPI (dark blue) was used as a nuclear counter stain.
Microscopy and pseudocoloring of individual Opal™ dyes was performed using a Vectra 3 Imaging System (Akoya Biosciences®).
This data is courtesy of ImmunoAtlas and it can be found here.
This image is courtesy of ImmunoAtlas.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [236A/E7] (AB20034)
Immunohistochemical analysis of formalin fixed paraffin embedded human tonsil labelling FOXP3 with ab20034 at a concentration of 2 µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with an OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was conducted for 32 mins at 100°C with ULTRA cell conditioning solution (CC1, pH 8.5). ab20034 anti-FOXP3 antibody [236A/E7] was incubated at 37°C for 16 mins. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [236A/E7] (AB20034)
Immunohistochemical analysis of paraffin-embedded human thymus tissue labeling FOXP3 with ab23004 at 1/500 dilution followed by a ready to use Goat Anti-Mouse IgG. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is a ready to use Goat Anti-Mouse IgG.
Perform heat mediated antigen retrieval using Tris/EDTA buffer (pH 9.0).
- IHC-P
PubMed
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [236A/E7] (AB20034)
FoxP3+ cells mainly accumulate centrally.
The formalin-fixed, paraffin-embedded blocks were cut into approximately <2 μm thick slices and mounted on SuperFrost Plus microscope slides (Menzel Gläser, Braunschweig, Germany). After deparaffinization and rehydration, sections were immersed into Dako Target Retrieval solution (Dako North America Inc., Carpinteria, USA), pH 6, 1/10, incubated at 97°C–99°C at 750 Watt for 2x 15 minutes, and allowed to cool to room temperature for 20 minutes. Endogenous peroxidase activity was blocked by 10-minute incubation in 7.5% hydrogen-peroxide solution (Hydroxen Peroxide Solution, Sigma Aldrich Co., Munich, Germany). Immunohistochemical staining for FoxP3 (1/180 dilution; for 60 min) was performed according to standard procedure using MACH-3 mouse alkalic phosphatase polymer detection kit from Biocare Medical Systems (Concord, USA). The slides were incubated with monoclonal mouse antibody. Chromogen Red (Dako North Amerika Inc., Carpinteria, USA) was used as chromogen for FoxP3 staining, and lastly hematoxylin counterstaining was done (Vector Laboratories, Burlingam, USA).
This image was generated from the hybridoma version of the product.
Hermans C. et al PLoS One. 2014 Nov 3;9(11):e111757. doi: 10.1371/journal.pone.0111757. eCollection 2014. Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/
- mIHC
Collaborator
Multiplex immunohistochemistry - Anti-FOXP3 antibody [236A/E7] (AB20034)
Fluorescence multiplex immunohistochemical analysis of Human breast cancer tissue (formalin-fixed paraffin-embedded section).
Merged staining of Anti-PD-L1 (ab251611; cyan; Opal™ 520), Anti-Granzyme B (ab219803; yellow; Opal™ 540), Anti-PD1 (ab251613; magenta; Opal™ 570), Anti-pan Cytokeratin (ab264485; red; Opal™ 620), Anti-EpCAM (ab225894; red; Opal™ 620), Anti-CD8 alpha (ab251596; green; Opal™ 650) and Anti-FOXP3 (ab96048; orange; Opal™ 690). EpCAM and pan-cytokeratin share the same dye and color. Dyes are pseudo-colored for better contrast of the markers.
The immunostaining was performed on a Leica Biosystems BOND® MAX instrument with an Opal™ 6-Plex Detection Kit (NEL821001KT, Akoya Biosciences®).
The section was incubated in six rounds of staining; sequentially for ab251611 (1/750 dilution), ab219803 (1/250 dilution), ab251613 (1/750 dilution), ab264485 (0.5 μg/ml), ab225894 (1/1250 dilution), ab251596 (1/1500 dilution) and ab96048 (10 μg/ml); each using a separate fluorescent tyramide signal amplification system. EDTA based antigen retrieval (Leica Biosystems BOND® Epitope Retrieval Solution 2, pH 9.0, 20 minutes) was used in between rounds of tyramide signal amplification to remove the antibody from the previous round, to avoid any cross-reactivity. DAPI (dark blue) was used as a nuclear counter stain.
Microscopy and pseudocoloring of individual Opal™ dyes was performed using a Vectra 3 Imaging System (Akoya Biosciences®).
This data is courtesy of ImmunoAtlas and it can be found here.
This image is courtesy of ImmunoAtlas.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [236A/E7] (AB20034)
Immunohistochemical analysis of formalin fixed paraffin embedded) human tonsil labelling FOXP3 with ab20034 at a concentration of 2 µg/ml. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with a Bond™ Polymer Refine Detection kit. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution 2) for 20 mins. ab20034 anti-FOXP3 antibody [236A/E7] was incubated for 30 mins at room temperature. Sections were counterstained with Hematoxylin. Image inset shows absence of staining in secondary antibody only control.
- IHC-P
AbReview16484****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [236A/E7] (AB20034)
ab20034 staining FOXP3 in human colon tissue section by Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections). Tissue underwent formaldehyde fixation before heat mediated antigen retrieval and then blocking with 10% serum for 2 hours at 21°C. The primary antibody was diluted 1/50 and incubated with sample for 2 hours at 21°C. An Alexa Fluor®488-conjugated rabbit polyclonal to mouse IgG was used undiluted as secondary antibody.
This image was generated from the hybridoma version of the product.
This image is a courtesy of Nicole Schechter
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [236A/E7] (AB20034)
Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling FOXP3 with ab23004 at 1/500 dilution followed by a ready to use Goat Anti-Mouse IgG. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody secondary antibody is a ready to use Goat Anti-Mouse IgG.
Perform heat mediated antigen retrieval using Tris/EDTA buffer (pH 9.0).
- mIHC
Collaborator
Multiplex immunohistochemistry - Anti-FOXP3 antibody [236A/E7] (AB20034)
Fluorescence multiplex immunohistochemical analysis of Human breast cancer tissue (formalin-fixed paraffin-embedded section).
Merged staining of Anti-PD-L1 (ab251611; cyan; Opal™ 520), Anti-Granzyme B (ab219803; yellow; Opal™ 540), Anti-PD1 (ab251613; magenta; Opal™ 570), Anti-pan Cytokeratin (ab264485; red; Opal™ 620), Anti-EpCAM (ab225894; red; Opal™ 620), Anti-CD8 alpha (ab251596; green; Opal™ 650) and Anti-FOXP3 (ab96048; orange; Opal™ 690). EpCAM and pan-cytokeratin share the same dye and color. Dyes are pseudo-colored for better contrast of the markers.
The immunostaining was performed on a Leica Biosystems BOND® MAX instrument with an Opal™ 6-Plex Detection Kit (NEL821001KT, Akoya Biosciences®).
The section was incubated in six rounds of staining; sequentially for ab251611 (1/750 dilution), ab219803 (1/250 dilution), ab251613 (1/750 dilution), ab264485 (0.5 μg/ml), ab225894 (1/1250 dilution), ab251596 (1/1500 dilution) and ab96048 (10 μg/ml); each using a separate fluorescent tyramide signal amplification system. EDTA based antigen retrieval (Leica Biosystems BOND® Epitope Retrieval Solution 2, pH 9.0, 20 minutes) was used in between rounds of tyramide signal amplification to remove the antibody from the previous round, to avoid any cross-reactivity. DAPI (dark blue) was used as a nuclear counter stain.
Microscopy and pseudocoloring of individual Opal™ dyes was performed using a Vectra 3 Imaging System (Akoya Biosciences®).
This data is courtesy of ImmunoAtlas and it can be found here.
This image is courtesy of ImmunoAtlas.
- IHC-P
PubMed
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [236A/E7] (AB20034)
Immunohistochemical analysis of human large and locally advanced breast cancers staining FOXP3 using ab20034. (a) Low level of FOXP3+, CTLA-4+ Treg infiltration (b) High level of FOXP3+ and CTLA-4+ Treg infiltration. (Itu : intratumoral Str : stromal)
This image was generated from the hybridoma version of the product.
This image is from PubMedId: 27777963. Kaewkangsadan V et al. (2016) Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/
- mIHC
Collaborator
Multiplex immunohistochemistry - Anti-FOXP3 antibody [236A/E7] (AB20034)
Fluorescence multiplex immunohistochemical analysis of Human breast cancer tissue (formalin-fixed paraffin-embedded section).
Merged staining of Anti-PD-L1 (ab251611; cyan; Opal™ 520), Anti-Granzyme B (ab219803; yellow; Opal™ 540), Anti-PD1 (ab251613; magenta; Opal™ 570), Anti-pan Cytokeratin (ab264485; red; Opal™ 620), Anti-EpCAM (ab225894; red; Opal™ 620), Anti-CD8 alpha (ab251596; green; Opal™ 650) and Anti-FOXP3 (ab96048; orange; Opal™ 690). EpCAM and pan-cytokeratin share the same dye and color. Dyes are pseudo-colored for better contrast of the markers.
The immunostaining was performed on a Leica Biosystems BOND® MAX instrument with an Opal™ 6-Plex Detection Kit (NEL821001KT, Akoya Biosciences®).
The section was incubated in six rounds of staining; sequentially for ab251611 (1/750 dilution), ab219803 (1/250 dilution), ab251613 (1/750 dilution), ab264485 (0.5 μg/ml), ab225894 (1/1250 dilution), ab251596 (1/1500 dilution) and ab96048 (10 μg/ml); each using a separate fluorescent tyramide signal amplification system. EDTA based antigen retrieval (Leica Biosystems BOND® Epitope Retrieval Solution 2, pH 9.0, 20 minutes) was used in between rounds of tyramide signal amplification to remove the antibody from the previous round, to avoid any cross-reactivity. DAPI (dark blue) was used as a nuclear counter stain.
Microscopy and pseudocoloring of individual Opal™ dyes was performed using a Vectra 3 Imaging System (Akoya Biosciences®).
This data is courtesy of ImmunoAtlas and it can be found here.
This image is courtesy of ImmunoAtlas.
- mIHC
Collaborator
Multiplex immunohistochemistry - Anti-FOXP3 antibody [236A/E7] (AB20034)
Fluorescence multiplex immunohistochemical analysis of Human breast cancer tissue (formalin-fixed paraffin-embedded section).
Merged staining of Anti-PD-L1 (ab251611; cyan; Opal™ 520), Anti-Granzyme B (ab219803; yellow; Opal™ 540), Anti-PD1 (ab251613; magenta; Opal™ 570), Anti-pan Cytokeratin (ab264485; red; Opal™ 620), Anti-EpCAM (ab225894; red; Opal™ 620), Anti-CD8 alpha (ab251596; green; Opal™ 650) and Anti-FOXP3 (ab96048; orange; Opal™ 690). EpCAM and pan-cytokeratin share the same dye and color. Dyes are pseudo-colored for better contrast of the markers.
The immunostaining was performed on a Leica Biosystems BOND® MAX instrument with an Opal™ 6-Plex Detection Kit (NEL821001KT, Akoya Biosciences®).
The section was incubated in six rounds of staining; sequentially for ab251611 (1/750 dilution), ab219803 (1/250 dilution), ab251613 (1/750 dilution), ab264485 (0.5 μg/ml), ab225894 (1/1250 dilution), ab251596 (1/1500 dilution) and ab96048 (10 μg/ml); each using a separate fluorescent tyramide signal amplification system. EDTA based antigen retrieval (Leica Biosystems BOND® Epitope Retrieval Solution 2, pH 9.0, 20 minutes) was used in between rounds of tyramide signal amplification to remove the antibody from the previous round, to avoid any cross-reactivity. DAPI (dark blue) was used as a nuclear counter stain.
Microscopy and pseudocoloring of individual Opal™ dyes was performed using a Vectra 3 Imaging System (Akoya Biosciences®).
This data is courtesy of ImmunoAtlas and it can be found here.
This image is courtesy of ImmunoAtlas.
- WB
Lab
Western blot - Anti-FOXP3 antibody [236A/E7] (AB20034)
ab20034 detects Human FOXP3 protein at ~50 kDa in HEK293T cells overexpressing the protein. It also detects FOXP3 in Human tonsil tissue lysate, however this band is significantly weaker in endogenous conditions. Upon higher exposure, weak bands can also be observed in HEK293T cell lysate.
This blot was produced using a 4-12% Bis-Tris gel under the MOPS buffer system. The gel was run at 200V for 60 minutes before being transferred onto a nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour before being incubated with Anti-FOXP3 antibody [236A/E7] (ab20034; 5 microgram per mL) overnight at 4°C. Antibody binding was detected using infrared labelled goat anti-mouse (green; 1 : 10000) for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-FOXP3 antibody [236A/E7] (ab20034) at 5 µg/mL
Lane 1:
HEK293T cell lysate at 20 µg
Lane 2:
HEk293T cell lysate overexpressing Human FOXP3 at 20 µg
Lane 3:
Human tonsil tissue lysate at 20 µg
Predicted band size: 47 kDa
false
- WB
Unknown
Western blot - Anti-FOXP3 antibody [236A/E7] (AB20034)
All lanes:
Western blot - Anti-FOXP3 antibody [236A/E7] (ab20034) at 1/1000 dilution
All lanes:
Human mammary gland lysate at 20 µg
Predicted band size: 47 kDa
false
- IHC-P
AbReview30757****
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FOXP3 antibody [236A/E7] (AB20034)
ab20034 staining FOXP3 in Cynomolgus Monkey Spleen tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed paraffin-embedded sections). Tissue was fixed with formaldehyde and blocked with 10% donkey serum for 20 minutes at room temperature; antigen retrieval was by heat mediation using EDTA pH9.0. Samples were incubated with primary antibody (1/100 dilution) for 30 minutes. A Biotin-conjugated Donkey anti-mouse polyclonal (1/2000 dilution) was used as the secondary antibody.
This image was generated from the hybridoma version of the product.
Image is courtesy of an AbReview submitted by Jing Ma
- WB
Unknown
Western blot - Anti-FOXP3 antibody [236A/E7] (AB20034)
All lanes:
Western blot - Anti-FOXP3 antibody [236A/E7] (ab20034) at 1/1000 dilution
Lane 1:
HEK-293 (human embryonic kidney) transfected with an empty vector (vector control), containing a GFP-Myc-tag, whole cell lysate at 10 µg
Lane 2:
HEK-293 transfected with FOXP3 (WT) expression vector containing a GFP-Myc-tag, whole cell lysate at 10 µg
Predicted band size: 47 kDa
false
Exposure time: 1s
Related conjugates and formulations (1)
-
Anti-FOXP3 antibody [236A/E7] - BSA and Azide free
Reactivity data
Product details
Anti-FOXP3 antibody [236A/E7] (ab20034) was first used in a scientific publication in 2005 and has been cited over 593 times in peer reviewed journals. It's performance in IHC in human samples is trusted by the scientific community.
Abcam's high quality manufacturing and validation processes ensure Anti-FOXP3 antibody [236A/E7] (ab20034) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-FOXP3 antibody [236A/E7] (ab20034) has 37 independent reviews from customers.
Anti-FOXP3 antibody [236A/E7] (ab20034) specifically detects FOXP3 (UniProt ID: Q9BZS1; Molecular weight: 48kDa) and is sold in a convenient trial size to enable initial testing (10ug, 20 µg) and larger sizes for subsequent scaling up experiments (100 µg and 1 mg).
Conjugation-ready, carrier free format available for antibody clone 236A/E7 - ab96048.
FOXP3 is essential for the development and function of regulatory T cells (Tregs), which help maintain immune tolerance. In cancer, FOXP3-expressing Tregs suppress anti-tumor immune responses, aiding tumor growth and progression.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The regulatory role of FOXP3 in T cells influences the immune response. It is a part of the Treg cell lineage and serves by modulating cytokine expression. In particular FOXP3 contributes to the suppression of effector T cell functions mediating immune homeostasis. Without FOXP3 Treg cells lose their function and ability to regulate immune responses effectively. The complexity of Treg cell function is partly attributed to the multitude of interactions FOXP3 facilitates within cell signaling pathways. In research scientists frequently utilize FOXP3 antibodies like 236A/E7 and 3G3 to study its expression and function in various biological contexts.
Pathways
FOXP3 integrates into the regulatory framework of pathways such as the TGF-beta signaling and IL-2 signaling pathways. These pathways are important for Treg differentiation and regulatory capacity. FOXP3 interacts with the signaling molecules and co-factors within these pathways including SMAD3 in the TGF-beta pathway aligning with its role in Treg functionality. FOXP3 functions alongside proteins like RUNX1 and CTLA-4 which further modulates its regulatory effects on T cell activity. These interactions illustrate FOXP3's extensive reach within immune regulation and development.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (746)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:35240 PubMed41068337
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:8918 PubMed41057358
2025
Applications
Unspecified application
Species
Unspecified reactive species
Discover oncology 16:1800 PubMed41037138
2025
Applications
Unspecified application
Species
Unspecified reactive species
Communications medicine 5:407 PubMed41028530
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of gastrointestinal oncology 16:1366-1379 PubMed40950351
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 17: PubMed40940828
2025
Applications
Unspecified application
Species
Unspecified reactive species
APL bioengineering 9:036115 PubMed40895767
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC medicine 23:498 PubMed40859356
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:588 PubMed40759637
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 17: PubMed40723259
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com